Today announcement after hour of the options exercise price of $32.11 per share is an indication of good news tomorrow. Good luck to all longs and believers in this company and its medications.
I guess that investors are bailing out based on a bird on hand is better than ten on a tree theory. I'm holding my shares anticipating news at any minutes to send it skyrocket. I believe we have a winner here based on families feed back on their kid progress.
Heck to the no, but the writing on the wall as they say. The stock behavior the last three weeks says it all. I'm in since mid 20's and I won't be out if it hits three digit either. A buyout or in its own, Serapta will reach there God willing.
Man, it seems like you all in here for all mighty dollar only. Money can't buy happiness. Just ask any family with a kid suffering of DMD.
Just 9 weeks in, this treatment looks like it is slowing down that progression.
"We've noticed that he's getting up faster. I'm not having to help him as much," says Ashley.
Total revenues increased 100.9% to kEUR 5,484 from kEUR 2,730
• Systems revenues increased 56.6% to kEUR 1,933 from kEUR 1,234
• Services revenues increased 137.4% to kEUR 3,551 from kEUR 1,496
• Gross margin was 33.5% compared to 31.5% in the prior year quarter
• Reaffirm full year 2015 revenue guidance
Stop loss though isn't going to help you out if the company drop from 50 to 20 after a halt. You ain't going to get the stop loss price you sat period. Beside, big boys who short appreciate the stop loss of small investors.